Last reviewed · How we verify
Placebo Inhalation Powder NDPI
Placebo Inhalation Powder NDPI is a Small molecule drug developed by GlaxoSmithKline. It is currently in Phase 3 development for Control arm in phase 3 clinical trials (non-therapeutic use). Also known as: ACCUHALER and DISKUS are registered trade marks of the GlaxoSmithKline Group of companies.
Placebo has no active pharmacological mechanism and produces no therapeutic effect beyond the placebo response.
Placebo has no active pharmacological mechanism and produces no therapeutic effect beyond the placebo response. Used for Control arm in phase 3 clinical trials (non-therapeutic use).
At a glance
| Generic name | Placebo Inhalation Powder NDPI |
|---|---|
| Also known as | ACCUHALER and DISKUS are registered trade marks of the GlaxoSmithKline Group of companies |
| Sponsor | GlaxoSmithKline |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
Placebo is an inert substance used as a control in clinical trials to measure the effect of expectation and natural disease progression independent of active drug treatment. It serves as a comparator to establish the true efficacy of investigational therapies by isolating the pharmacological effect from psychological and contextual factors.
Approved indications
- Control arm in phase 3 clinical trials (non-therapeutic use)
Common side effects
Key clinical trials
- A 24 Week Efficacy Study of Inhaled Umeclidinium (UMEC) in Patients of Chronic Obstructive Pulmonary Disease (COPD) Using a Novel Dry Powder Inhaler (NDPI) (PHASE3)
- A Study to Assess the Efficacy of Fluticasone Furoate/Vilanterol (FF/VI) Inhalation Powder 100/25 mcg Once Daily Compared With Fluticasone Propionate/Salmeterol Inhalation Powder 250/50 mcg Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD) (PHASE3)
- A 12-week Study to Evaluate the Efficacy and Safety of Umeclidinium Compared With Tiotropium in Subjects With Chronic Obstructive Pulmonary Disease (PHASE3)
- A Study to Compare the Efficacy and Safety of Umeclidinium/Vilanterol and Fluticasone Propionate/Salmeterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD) (PHASE3)
- A Study to Compare the Efficacy and Safety of Umeclidinium/Vilanterol With Fluticasone Propionate/Salmeterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD) (PHASE3)
- Study B2C112060: A Study of the Efficacy and Safety of Vilanterol Inhalation Powder in Adults and Adolescents With Persistent Asthma (PHASE3)
- A Study to Evaluate the Efficacy and Safety of Umeclidinium Bromide/Vilanterol Compared With Fluticasone Propionate/Salmeterol Over 12 Weeks in Subjects With Chronic Obstructive Pulmonary Disease (COPD) (PHASE3)
- Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry. (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo Inhalation Powder NDPI CI brief — competitive landscape report
- Placebo Inhalation Powder NDPI updates RSS · CI watch RSS
- GlaxoSmithKline portfolio CI
Frequently asked questions about Placebo Inhalation Powder NDPI
What is Placebo Inhalation Powder NDPI?
How does Placebo Inhalation Powder NDPI work?
What is Placebo Inhalation Powder NDPI used for?
Who makes Placebo Inhalation Powder NDPI?
Is Placebo Inhalation Powder NDPI also known as anything else?
What development phase is Placebo Inhalation Powder NDPI in?
Related
- Manufacturer: GlaxoSmithKline — full pipeline
- Indication: Drugs for Control arm in phase 3 clinical trials (non-therapeutic use)
- Also known as: ACCUHALER and DISKUS are registered trade marks of the GlaxoSmithKline Group of companies
- Compare: Placebo Inhalation Powder NDPI vs similar drugs
- Pricing: Placebo Inhalation Powder NDPI cost, discount & access